title: Venlafaxine, serotonin syndrome, and differential diagnoses.
authors.forename: F
authors.initials: F
authors.lastname: Montañes-Rada
authors.forename: J
authors.initials: J
authors.lastname: Bilbao-Garay
authors.forename: M T
authors.initials: MT
authors.lastname: de Lucas-Taracena
authors.forename: M E
authors.initials: ME
authors.lastname: Ortiz-Ortiz
mesh_terms: D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D002389:Catatonia / Q000175:diagnosis; D003511:Cyclohexanols / Q000009:adverse effects*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis; D020230:Serotonin Syndrome / Q000175:diagnosis* / Q000523:psychology*; D000069470:Venlafaxine Hydrochloride
chemical_list: D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride